The Absence of Somatotroph Proliferation During Continuous Stress is a Result of the Lack of Extracellular Signal-Regulated Kinase 1/2 Activation

Journal of Neuroendocrinology

Volumn 24, Issue 10, 2012, Pages 1335-1345

  Ogawa, T ^a   Sei, H ^b   Konishi, H ^c   Shishioh Ikejima, N ^a   Kiyama, H ^a,c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic fatigue syndrome; Chronic stress; Fibromyalgia; Growth hormone; Hypothalamus; Pituitary

Indexed keywords

CORTICOSTERONE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL MODEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE SECRETING CELL; HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SECRETORY GRANULE; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CHRONIC DISEASE; CORTICOSTERONE; ENZYME ACTIVATION; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PITUITARY GLAND, ANTERIOR; PROTEIN TRANSPORT; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SOMATOTROPHS; STRESS, PSYCHOLOGICAL;

EID: 84866323092     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02338.x     Document Type: Article

References (33)

1. Tanaka M, Nakamura F, Mizokawa S, Matsumura A, Nozaki S, Watanabe Y. Establishment and assessment of a rat model of fatigue. Neurosci Lett 2003; 352: 159-162.
2. Ogawa T, Kiryu-Seo S, Tanaka M, Konishi H, Iwata N, Saido T, Watanabe Y, Kiyama H. Altered expression of neprilysin family members in the pituitary gland of sleep-disturbed rats, an animal model of severe fatigue. J Neurochem 2005; 95: 1156-1166.
3. Ogawa T, Shishioh-Ikejima N, Konishi H, Makino T, Sei H, Kiryu-Seo S, Tanaka M, Watanabe Y, Kiyama H. Chronic stress elicits prolonged activation of alpha-MSH secretion and subsequent degeneration of melanotroph. J Neurochem 2009; 109: 1389-1399.
4. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC. Metabolic regulation of brain Abeta by neprilysin. Science 2001; 292: 1550-1552.
5. Kiryu-Seo S, Sasaki M, Yokohama H, Nakagomi S, Hirayama T, Aoki S, Wada K, Kiyama H. Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers. Proc Natl Acad Sci USA 2000; 97: 4345-4350.
6. Konishi H, Ogawa T, Nakagomi S, Inoue K, Tohyama M, Kiyama H. Id1, Id2 and Id3 are induced in rat melanotrophs of the pituitary gland by dopamine suppression under continuous stress. Neuroscience 2010; 169: 1527-1534.
7. Konishi H, Ogawa T, Kawahara S, Matsumoto S, Kiyama H. Continuous stress-induced dopamine dysregulation augments PAP-I and PAP-II expression in melanotrophs of the pituitary gland. Biochem Biophys Res Commun 2011; 407: 7-12.
8. Wallymahmed ME, Foy P, MacFarlane IA. The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clin Endocrinol (Oxf) 1999; 51: 333-338.
9. Kiryu S, Yao GL, Morita N, Kato H, Kiyama H. Nerve injury enhances rat neuronal glutamate transporter expression: identification by differential display PCR. J Neurosci 1995; 15: 7872-7878.
10. Oishi Y, Okuda M, Takahashi H, Fujii T, Morii S. Cellular proliferation in the anterior pituitary gland of normal adult rats: influences of sex, estrous cycle, and circadian change. Anat Rec 1993; 235: 111-120.
11. Taniguchi Y, Yasutaka S, Kominami R, Shinohara H. Proliferation and differentiation of rat anterior pituitary cells. Anat Embryol 2002; 206: 1-11.
12. Rhodin JAG. Hyphophysis. In: Rhodin JAG, ed. Histology: A Text and Atras. Oxford: Oxford University Press, 1975: 429-439.
13. Lania A, Filopanti M, Corbetta S, Losa M, Ballare E, Beck-Peccoz P, Spada A. Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells. J Clin Endocrinol Metab 2003; 88: 1692-1696.
14. Pombo CM, Zalvide J, Gaylinn BD, Dieguez C. Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 2000; 141: 2113-2119.
15. Endl E, Gerdes J. The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 2000; 257: 231-237.
16. Leblond CP, El-Alfy M. The eleven stages of the cell cycle, with emphasis on the changes in chromosomes and nucleoli during interphase and mitosis. Anat Rec 1998; 252: 426-443.
17. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-322.
18. Shirasawa N, Yoshimura F. Immunohistochemical and electron microscopical studies of mitotic adenohypophysial cells in different ages of rats. Anat Embryol 1982; 165: 51-61.
19. Senaris RM, Lago F, Coya R, Pineda J, Dieguez C. Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids. Endocrinology 1996; 137: 5236-5241.
20. Zeitler P, Siriwardana G. Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone. Endocrine 2000; 12: 257-264.
21. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001; 20: 7108-7116.
22. Clark AR, Lasa M. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol 2003; 3: 404-411.
23. Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003; 24: 236-252.
24. Evans KM, Flanagan DE, Wilkin TJ. Chronic fatigue: is it endocrinology? Clin Med 2009; 9: 34-38.
25. Greenfield JR, Samaras K. Evaluation of pituitary function in the fatigued patient: a review of 59 cases. Eur J Endocrinol 2006; 154: 147-157.
26. Parker AJ, Wessely S, Cleare AJ. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 2001; 31: 1331-1345.
27. Allain TJ, Bearn JA, Coskeran P, Jones J, Checkley A, Butler J, Wessely S, Miell JP. Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry 1997; 41: 567-573.
28. Bennett RM. Disordered growth hormone secretion in fibromyalgia: a review of recent findings and a hypothesized etiology. Z Rheumatol 1998; 57(Suppl. 2): 72-76.
29. Moorkens G, Berwaerts J, Wynants H, Abs R. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin Endocrinol (Oxf) 2000; 53: 99-106.
30. Berwaerts J, Moorkens G, Abs R. Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Horm IGF Res 1998; 8(Suppl. B): 127-129.
31. Everson CA, Crowley WR. Reductions in circulating anabolic hormones induced by sustained sleep deprivation in rats. Am J Physiol Endocrinol Metab 2004; 286: E1060-E1070.
32. Obal F Jr, Alt J, Taishi P, Gardi J, Krueger JM. Sleep in mice with nonfunctional growth hormone-releasing hormone receptors. Am J Physiol Regul Integr Comp Physiol 2003; 284: R131-R139.
33. Zhang J, Obal F Jr, Zheng T, Fang J, Taishi P, Krueger JM. Intrapreoptic microinjection of GHRH or its antagonist alters sleep in rats. J Neurosci 1999; 19: 2187-2194.